Arkolith/Insider Trading/ASND/Form 4

Bienaime Jean Jacques

DirectorAscendis Pharma A/S (ASND) · full profile →Form 4 · filed Jun 1, 2026
Net Buying
Open-Market Buys
$112K
Open-Market Sells
$0
Net Open-Market Flow
$112K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 29, 2026Buy(P)200$223.76$45K600
May 29, 2026Buy(P)200$222.30$44K800
May 29, 2026Buy(P)100$223.50$22K900

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001610717-26-000177) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML